CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024 CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024 CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023 CTKB stock results show that Cytek Biosciences beat on revenue for the fourth quarter of 2023.
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says Stephens initiated coverage on Cytek Biosciences Inc (
NASDAQ: CTKB ), a manufacturer and supplier of flow cytometry products and services.
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Butterfly Network, Inc. (
NASDAQ: BFLY ) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
